Cybin Inc. (NYSE AMERICAN: CYBN)
$0.31
-0.0128 ( -3.94% ) 4.9M
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
Market Data
Open
$0.31
Previous close
$0.32
Volume
4.9M
Market cap
$239.31M
Day range
$0.30 - $0.33
52 week range
$0.25 - $0.74
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k/a | Quarterly Reports | 1 | Nov 13, 2023 |
6-k/a | Quarterly Reports | 28 | Nov 13, 2023 |
6-k | Quarterly Reports | 3 | Nov 13, 2023 |
6-k | Quarterly Reports | 3 | Nov 03, 2023 |
6-k | Quarterly Reports | 3 | Nov 01, 2023 |
6-k | Quarterly Reports | 5 | Nov 01, 2023 |
6-k | Quarterly Reports | 3 | Oct 27, 2023 |
6-k | Quarterly Reports | 2 | Oct 26, 2023 |
6-k | Quarterly Reports | 3 | Oct 26, 2023 |
6-k | Quarterly Reports | 3 | Oct 25, 2023 |